机译:改善修订的国际预后评分系统前同种异体干细胞移植不会转化为骨髓增生综合征患者的更好的移植后结果:单中心经验
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Division of Hematology Department of Medicine University of British Columbia;
Myelodysplastic syndromes; Revised international prognostic scoring system; IPSS-R; Stem cell transplantation;
机译:改善修订的国际预后评分系统前同种异体干细胞移植不会转化为骨髓增生综合征患者的更好的移植后结果:单中心经验
机译:枚举骨髓胚胎来自壬虫细胞性的骨髓爆炸改善了骨髓增强症综合征的结果预测,并允许更好地定义修订的国际预后评分系统的中间风险类别(IPSS-R)
机译:经修订的国际预后评分系统和法国预后评分系统对阿扎胞苷治疗的骨髓增生异常综合征患者的预后效用比较
机译:大剂量化学疗法和自体干细胞拯救治疗的Theratope(STn-KLH)癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果:自体移植后的Theratope(STn-KLH)癌症疫苗
机译:自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
机译:修订后的国际预后评分系统细胞遗传学和单核染色体核型对骨髓增生异常综合症和继发于骨髓增生异常综合症的继发性急性髓性白血病的同种异体干细胞移植后结局的影响:欧洲血液和骨髓移植学会的一项回顾性多中心研究
机译:修订后的国际预后评分系统,细胞遗传学和单核染色体核型对骨髓增生异常综合征和继发于骨髓增生异常综合征的继发性急性髓性白血病的同种异体干细胞移植后预后的影响:欧洲血液和骨髓移植学会的一项回顾性多中心研究